The limitation of this study was, along with the limit of a cross-sectional investigation, the fact that other health factors, such as benign prostate disorders (benign prostate hyperplasia, prostatitis and others), might affect serum PSA levels, could not be completely controlled. Here, KLK3 is linked to benign prostatic hyperplasia.